Behbahani Ali (CIK 0001613867)

Latest company ownership

SVRA - Savara Inc
Role: 10% Owner
Shares held
24,471,264
Last filed at
Jul 19, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q3 2025Q4
Shares held
4,448,757
Last filed at
Jun 21, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q1 2025Q4
Shares held
3,000,000
Last filed at
Apr 13, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q2 2025Q4
MBX - MBX Biosciences, Inc.
Role: 10% Owner
Shares held
2,091,383
Last filed at
Sep 17, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q3 2025Q4
Shares held
1,625,678
Last filed at
Dec 23, 2024
Confidence Score
50.1
2025Q4
Confidence Score History
2021Q1 2025Q4
NEUE - NeueHealth, Inc.
Role: Director
Shares held
1,352,200
Last filed at
Oct 6, 2025
Confidence Score
32.2
2025Q4
Confidence Score History
2021Q2 2025Q4
Shares held
22,100
Last filed at
Jun 13, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4
Shares held
135
Last filed at
Jun 15, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q3 2025Q4
Shares held
0
Last filed at
Aug 19, 2025
Confidence Score
44.8
2025Q4
Confidence Score History
2018Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 2, 2025 Oct 6, 2025 NeueHealth, Inc. Director Sell 26.3 -4,224,034 -30.98% ✗ $33.2K
Aug 15, 2025 Aug 19, 2025 Adaptimmune Therapeutics PLC Director Sell 22.5 -19,500,000 -100.00% ✗ $229.2K
Dec 23, 2024 Dec 23, 2024 Marker Therapeutics, Inc. 10% Owner Buy 100.0 +554,250 51.73% ✗ $1.8M
Sep 16, 2024 Sep 17, 2024 MBX Biosciences, Inc. 10% Owner Buy 100.0 +500,000 16.05% ✗ $8M
Jul 17, 2023 Jul 19, 2023 Savara Inc 10% Owner Buy 85.0 +333,333 1.38% ✗ $1000K
Jul 5, 2023 Jul 6, 2023 Black Diamond Therapeutics, Inc. Director Buy 100.0 +1,000,000 28.66% ✗ $5M
Apr 11, 2022 Apr 13, 2022 Trevi Therapeutics, Inc. 10% Owner Buy 100.0 +3,580,526 45.96% ✗ $6.8M
Jun 28, 2021 Jun 30, 2021 NeueHealth, Inc. 10% Owner Buy 95.0 +1,944,444 2.78% ✗ $35M
Jun 28, 2021 Jun 30, 2021 Monte Rosa Therapeutics, Inc. Director Buy 100.0 +1,050,000 15.81% ✗ $20M
Mar 16, 2021 Mar 18, 2021 Marker Therapeutics, Inc. 10% Owner Buy 100.0 +5,714,285 114.29% ✗ $10M
Apr 3, 2020 Apr 13, 2020 Trevi Therapeutics, Inc. 10% Owner Sell 52.5 -564 -0.01% ✗ $1.5K
Feb 3, 2020 Feb 5, 2020 Black Diamond Therapeutics, Inc. Director Buy 100.0 +800,000 30.20% ✗ $15.2M
Jan 24, 2020 Jan 28, 2020 Adaptimmune Therapeutics PLC Director Buy 100.0 +7,500,000 62.50% ✗ $5M
Jul 22, 2019 Jul 24, 2019 Mirum Pharmaceuticals, Inc. 10% Owner Buy 100.0 +450,000 12.04% ✗ $6.8M
May 9, 2019 May 13, 2019 Trevi Therapeutics, Inc. 10% Owner Buy 100.0 +2,500,000 128.96% ✗ $25M
Sep 7, 2018 Sep 10, 2018 Adaptimmune Therapeutics PLC Director Buy 100.0 +12,000,000 100.00% ✗ $20M